40503-87-5Relevant articles and documents
HETEROARYL PYRROLIDINE AND PIPERIDINE OREXIN RECEPTOR AGONISTS
-
, (2021/02/12)
The present invention is directed to heteroaryl pyrrolidine and piperidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
5-ALKYL PYRROLIDINE OREXIN RECEPTOR AGONISTS
-
, (2020/08/25)
The present invention is directed to 5-alkyl pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.
Method for synthesizing trans-4-alkylcyclohexyl benzene structure liquid crystal intermediates and monomers
-
, (2018/03/01)
The invention discloses a method for synthesizing trans-4-alkylcyclohexyl benzene structure liquid crystal intermediates and monomers and belongs to the technical field of trans-cyclohexyl benzene liquid crystal. The method comprises the following steps: